Nachrichten zur Merck & Co. Inc. Aktie

Merck vor Milliardenübernahme von Krebsspezialisten

Der Darmstädter Merck-Konzern steht vor einer milliardenschweren Übernahme des US-Krebsspezialisten Springworks Therapeutics. Beide Unternehmen befänden sich in "weit fortgeschrittenen Gesprächen"…

Lohnt sich die Hauptversammlung für kleine Aktionäre?

Mit Merck, Bayer und Continental laden heute gleich drei große DAX-Konzerne ihre Anteilseigner zur Hauptversammlung ein. Was kann ein einzelner…

UBS belässt Merck KGaA auf Buy - Ziel 180 Euro

ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Merck KGaA auf "Buy" mit einem Kursziel von…

JPMorgan belässt Merck KGaA auf Overweight - Ziel 190 Euro

NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Merck KGaA mit einem Kursziel von 190 Euro…

Pharmabranche: Merck vor Milliardenübernahme von Krebsspezialisten

Der Pharmakonzern will sein Geschäft mit Krebsarzneien mit einem Milliarden-Zukauf stärken. Gespräche mit einem US-Unternehmen sind schon weit. Mit dem…

DAX weiter auf dem Vormarsch – Atoss, Bayer, Bechtle, Deutsche Telekom, DWS, K+S, Merck, Nordex im Check

Nachdem der DAX am Donnerstag die 22.000-Punkte-Marke zurückerobert hat, steht der deutsche Leitindex am Freitag vor der nächsten Hürde in…

DAX erneut höher: Bayer, Continental, Nordex, Alphabet, Merck, Infineon, Deutsche Telekom im Fokus

Kulmbach (www.aktiencheck.de) - Der DAX (ISIN DE0008469008/ WKN 846900) hat den Donnerstag mit leichten Gewinnen abschließen können, so Marion Schlegel…

DAX erneut höher: Bayer, Continental, Nordex, Alphabet, Merck, Infineon, Deutsche Telekom im Fokus

Der DAX hat den Donnerstag mit leichten Gewinnen abschließen können. Er ging letztendlich mit einem Plus von 0,5 Prozent auf…

DAX erneut höher: Bayer, Continental, Nordex, Alphabet, Merck, Infineon, Deutsche Telekom im Fokus

Der DAX hat den Donnerstag mit leichten Gewinnen abschließen können. Er ging letztendlich mit einem Plus von 0,5 Prozent auf…

Übernahme: Zeitung: Merck vor Kauf des US-Krebsspezialisten Springworks

Der deutsche Pharma- und Technologiekonzern Merck will den US-Krebsspezialisten Springworks Therapeutics übernehmen. Geplant ist wohl eine Transaktion im Volumen von…

Germanys Merck nears roughly $3.5 billion deal for SpringWorks, WSJ reports

Germanys Merck KGaA is nearing a roughly $3.5 billion deal for SpringWorks Therapeutics , the Wall Street Journal reported on…

Merck KGaA Nears Deal to Buy SpringWorks Therapeutics

Merck KGaA is nearing a deal to acquire SpringWorks Therapeutics Inc., people familiar with the matter said.…

Merck & Co Aktie: Gardasil-Einbruch trifft Konzern - Halozyme-Klage im Fokus

Kulmbach (www.aktiencheck.de) - Merck & Co-Aktienanalyse von "Der Aktionär": Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die…

Merck (MRK) Reports Q1 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for Merck (MRK) give a sense of how its business performed in the quarter ended…

ROUNDUP: Merck & Co senkt Ausblick - Millionenbelastung durch Zölle

RAHWAY (dpa-AFX) - Der von den USA losgetretene Zollstreit dürfte auch den US-Pharmakonzern Merck & Co…

US-Pharmakonzern Merck & Co senkt Ausblick - Millionenbelastung durch Zölle

RAHWAY (dpa-AFX) - Der von den USA losgetretene Zollstreit dürfte auch den US-Pharmakonzern Merck & Co…

Merck lowers profit outlook due to expected $200M tariff hit

Merck & Co Inc (NYSE:MRK, ETR:6MK) has lowered its full-year earnings forecast due to an expected $200 million hit from…

Merck posts higher profit, puts tariffs cost at $200 million

Merck on Thursday said its first-quarter adjusted profit rose 7% as lower costs helped offset a 2% decline in sales,…

Merck lowers profit outlook, partly due to $200 million expected tariff hit

Merck said the expected tariff charge primarily reflects levies between the U.S. and China, but does not account for Trumps…

Merck: Now A Single-Digit P/E With Double-Digit EPS Growth, Technical Support

…

Ahead of Merck (MRK) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics

Beyond analysts top -and-bottom-line estimates for Merck (MRK), evaluate projections for some of its key metrics to gain a better…

This Beaten-Down Artificial Intelligence (AI) Stock Just Got Some Great News: Time to Buy?

Artificial intelligence (AI) is taking over the world. Individuals and corporations are implementing the technology in their day-to-day lives and…

Merck (MRK) Earnings Expected to Grow: What to Know Ahead of Next Weeks Release

Merck (MRK) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming…

Merck Aktie: Die Darmstädter zwischen Pharma und Halbleitern - Handelskonflikte treffen beide Sparten

Wien (www.aktiencheck.de) - Merck-Aktienanalyse von der Raiffeisen Bank International AG: Raphael Schicho, Analyst der Raiffeisen Bank International AG (RBI), rät in…

The Zacks Analyst Blog Merck and AbbVie

Merck and AbbVie are included in this Analyst Blog.…

Merck (MRK) Stock Drops Despite Market Gains: Important Facts to Note

The latest trading day saw Merck (MRK) settling at $79.17, representing a -0.01% change from its previous close.…

Is Iovance Biotherapeutics a Millionaire-Maker?

Some investors see a striking similarity between lottery tickets and biotech stocks. In most cases, buying lottery tickets ends up…

MRK Investors Have the Opportunity to Lead the Merck Securities Fraud Lawsuit with Faruqi & Faruqi, LLP

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Merck To…

Investing $60,000 in These 3 Funds Could Generate Annual Income of Over $6,500

Income investors could pay attention to the price fluctuations of the assets they own. But they dont have to. What…

3 Magnificent Stocks That Could Double or More by 2030

When the stock market is as turbulent as it is these days, its easy to forget the times when things…

Pharmabranche: Neue Zolldrohungen für Arzneimittelhersteller – Aktien von Bayer und Merck fallen

Bislang waren Medikamente von Strafzöllen ausgenommen. Doch Trump droht, das schnell und „erheblich“ zu ändern. Die Pharmabranche fliegt massenhaft Produkte…

Is Vertex Pharmaceuticals Stock a Buy?

Investors seeking relief from the stock market turbulence at the start of 2025 should take a close look at Vertex…

Merck (MRK) Stock Moves -0.24%: What You Should Know

The latest trading day saw Merck (MRK) settling at $86.39, representing a -0.24% change from its previous close.…

Better Beaten-Down Stock to Buy: Pfizer Vs. Moderna

In 2020, many companies tried to develop effective coronavirus vaccines, but two ended up succeeding and dominating the field: Pfizer…

2 Beaten-Down Stocks to Buy and Hold for a Decade

Recent market volatility notwithstanding, equities generally deliver solid returns over long periods, like a decade. The key is to purchase…

Why Major Pharmaceutical Stocks Tumbled on Tuesday

Many investor eyes were on the pharmaceutical industry on Tuesday, and not necessarily for the right reasons. The Trump administrations…

Top Analyst Reports for Amazon, Oracle & Merck

Todays Research Daily features new research reports on 16 major stocks, including Amazon.com, Inc. (AMZN), Oracle Corp. (ORCL) and Merck…

Healthy Returns: AstraZeneca cholesterol pill shows promise as race with Merck heats up

AstraZenecas new cholesterol pill is showing promise, while the FTC urged a potential buyer of 23andMe to protect user data.…

Beat the S&P 500 With This Cash-Gushing Dividend Stock

Investors seeking relief from stock market volatility should take a closer look at Bristol Myers Squibb (NYSE: BMY). At the…

Why the Market Dipped But Merck (MRK) Gained Today

In the closing of the recent trading day, Merck (MRK) stood at $89.23, denoting a +1.86% change from the preceding…

Which Dow Jones Stock Is Cheaper, Amgen or Merck?

Four of the 30 stocks that make up the Dow Jones Industrial Average represent the healthcare sector. Within that group,…

Merck Gets EC Nod for 21-Valent Pneumococcal Jab Capvaxive

The European Commission approves MRKs pneumococcal 21-valent conjugate vaccine, Capvaxive, for pneumococcal vaccination in adults.…

Is Merck Stock a Bargain Buy?

Merck (NYSE: MRK) is a top healthcare company with one of the best drugs ever made in its portfolio: Keytruda.…

Why Pfizer Is My Largest Healthcare Position

Healthcare stocks have been out of vogue with investors since late 2022. Myriad reasons underlie the negative sentiment toward the…

Merck (MRK) Gains As Market Dips: What You Should Know

Merck (MRK) closed the most recent trading day at $88.11, moving +0.27% from the previous trading session.…

Why Summit Therapeutics Stock Slipped Today

Summit Therapeutics (NASDAQ: SMMT) stock did better than a lot of other equities during an otherwise forgettable trading session on…

Pharmaindustrie: Bayer stärkt Forschung an Krebsmedikamenten mit Zukauf in China

Nach Deals von Merck und Novo Nordisk kauft nun auch Bayer in China zu. Ein neues Medikament soll Patienten mit…

Why Pharma and Biotech Stocks Got Thrashed on Tuesday

As ever in the often quick-developing biotech and pharmaceutical sectors on Tuesday, companies posted a mix of positive and negative…

Merck signs deal with Jiangsu Hengrui worth up to $2 billion for access to heart drug

Merck has signed a deal with Jiangsu Hengrui Pharmaceuticals worth up to $2 billion, the companies said on Tuesday, giving…

Is Summit Therapeutics a Millionaire Maker?

Multiple paths to immense wealth exist. A few lucky people win the lottery. Some start successful businesses. Others invest in…